This company accelerates biomanufacturing breakthroughs by designing cell-specific culture media using an AI-driven platform. Their MediOP™ technology integrates AI, robotics, and cell biology to create custom media solutions for advanced therapies, biologics, and cellular agriculture. Multus offers services for tailored media design, catalog formulations, and scalable supply chains globally.
Funding
$12.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The cellular agriculture industry relies on expensive and often animal-derived growth media components like fetal bovine serum (FBS), which hinders scalability and increases production costs for cultivated meat and cell-based products. Traditional growth media formulations often lack the performance and food-safe certifications required for commercialization.
Solution
Multus develops animal-free growth media ingredients and formulations designed to reduce costs and improve the scalability of cellular agriculture. Their technology platform combines intelligent formulation design and novel ingredient discovery to create high-performance, food-safe alternatives to traditional serum-based media. Multus offers a range of products, including serum-free formulations and recombinant proteins, optimized for specific cell types and bioprocesses. These solutions enable cultivated meat and cell therapy companies to achieve price parity, enhance cell behavior, and meet stringent quality standards.
Target Audience
The primary customers are cultivated meat companies and cell therapy developers seeking animal-free, food-safe, and cost-effective growth media solutions for cell proliferation and bioprocess scale-up.
Features
- Serum-free media formulations that can fully replace FBS in mammalian cell culture
- Recombinant proteins, including vitronectin, that support cell adhesion and proliferation
- Media customization services to optimize formulations for specific cell lines and bioprocess requirements
- Food-grade ingredients and ISO 22000 certified manufacturing processes to ensure product safety
- Scalable manufacturing processes to meet the demands of the cultivated meat industry
- Products designed for both cultivated meat and cell therapy applications
- Media formulations optimized for adherent cells